Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Genetic alterations have been proven to be the promising biomarkers for ICI response. However, sex biases in genetic alterations have been often ignored in the field of immunotherapy, which might specially influence the anticancer immunity and immunotherapy efficacy in male or female patients. |